Go to Bing homepage
Go to Bing homepage

Spark Therapeutics’ ground-breaking gene therapy Luxturna is now being used to treat patients with a rare, inherited eye condition at a small …
The Business Journals · 2d
A new FDA-approved gene therapy treatment for patients with an inherited form of vision loss is now available at Baylor College of Medicine. The …
Baylor College of Medicine · 6d
Last year also ushered in Luxturna from Spark Therapeutics, a gene therapy to treat a rare form of inherited blindness. This week, …
FiercePharma · 10d
Narasimhan’s own report card for the year: the company bought a company that makes radiopharmaceuticals in January, and licensed the international …
Forbes · 13d
Engl. J. Med. 2017, DOI: 10.1056/NEJMoa1706198). Gene therapy enthusiasm grew even more in December when Luxturna became the first …
C&EN · 12d
After a roller-coaster history of high hopes and major disappointments, the field of gene therapy has finally started showing promise for several …
NPR · 4d
The company obtained FDA approval for its lead gene therapy drug, Luxturna (voretigene neparvovec-rzyl), for the treatment of patients with viable retinal cells and confirmed biallelic RPE65 mutation-associated retinal …
Yahoo Finance · 9d
Access to gene therapy manufacturing is also spurring M&A ... reducing financial returns. Spark’s Luxturna has already been caught in …
Reuters · 11d
setting in motion a train of events that culminated March 20 at Children’s Hospital Los Angeles when he became the first adult to undergo the first …
Republican-American · 9d
This is Novartis’s second notable gene therapy deal this year after it agreed to pay $105 million upfront and up to $65 million in milestone payments for …
Reuters · 13d